NCT00947115View on ClinicalTrials.gov

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

525

Participants

Timeline

Start Date

September 22, 2009

Primary Completion Date

February 3, 2015

Study Completion Date

February 3, 2015

Conditions
Infections, Papillomavirus
Interventions
PROCEDURE

Blood sampling

Blood samples were collected at Years 5, 6, 7, 8, 9 and 10.

PROCEDURE

Cervico-vaginal secretion (CVS) samples

CVS samples were collected at Years 5, 6, 7, 8, 9 and 10 in subjects who volunteered for this procedure.

Trial Locations (6)

12200

GSK Investigational Site, Berlin

80637

GSK Investigational Site, Munich

97070

GSK Investigational Site, Würzburg

85-079

GSK Investigational Site, Bydgoszcz

60-535

GSK Investigational Site, Poznan

61-709

GSK Investigational Site, Poznan

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY